China Pharmaceuticals and Healthcare Report Q1 2014

LONDON, April 14, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

China Pharmaceuticals and Healthcare Report Q1 2014


Includes 3 FREE quarterly updates

BMI View:

Multinational pharmaceutical firms' commitment to the Chinese market is underpinned by the
potential of the healthcare sector. The sector itself is supported by consistent government efforts, thereby
increasing patients' access to these drugs. We would also highlight risks of operating in China, such as the
anti-bribery investigation and volatility caused by tender timings.

Headline Expenditure Projections

• Pharmaceuticals: CNY453.2bn (US$71.8bn) in 2012 to CNY532.4bn (US$85.9bn) in 2013; +17.5% in
local currency and +19.6% in US dollar terms. Forecast unchanged from Q413.
• Healthcare: CNY2845.6bn (US$451.1bn) in 2012 to CNY3281.6bn (US$527.6bn) in 2013; +15.3% in
local currency terms and +17.0% in US dollar terms. Forecast unchanged from Q413.
BMI Industry View 7
SWOT 9
Political 11
Economic 12
Business Environment 13
Industry Forecast 14
Pharmaceutical Market Forecast 14
Table: Pharmaceutical Sales Indicators, 2009-2017 16
Healthcare Market Forecast 16
Table: Healthcare Expenditure Indicators 2009-2017 18
Table: Healthcare Governmental Indicators 2009-201719
Table: Healthcare Private Indicators 2009-2017 19
Prescription Drug Market Forecast 20
Table: Prescription Drug Sales Indicators, 2009-2017 22
Patented Drug Market Forecast 22
Table: Patented Drug Market Indicators, 2009-201723
Generic Drug Market Forecast 24
Table: China Generic Drug Sales Indicators, 2009-2017 25
OTC Medicine Market Forecast 26
Regulatory Regime 28
Table: OTC Medicine Sales Indicators 2009-201729
Pharmaceutical Trade Forecast 30
Table: China Export And Import Indicators, 2009-2017 32
Other Healthcare Data 32
Key Risks To BMI's Forecast Scenario 33
Macroeconomic Forecasts 35
Economic Analysis 35
Table: China - Economic Activity 40
Industry Risk Reward Ratings 41
Asia Pacific Risk/Reward Ratings 41
China Risk/Reward Ratings 47
Rewards 47
Risks 47
Market Overview 49
Industry Trends And Developments 51
Epidemiology 51
Table: Death Rate Of Major Diseases In Urban And Rural Areas (2011)54
Healthcare Sector 54
Research And Development 62
Table: Selected List Of MNC With R&D Bases In China 62
Table: Selected List Of Collaboration In R&D Operations In China 68
Clinical Trials 70
Biotechnology Sector 73
Regulatory Development 80
Regulatory Regime 80
Table: Important China GMP Deadlines 84
Intellectual Property Issues 84
Pricing Regime 90
Reimbursement Regime 99
Competitive Landscape 103
Pharmaceutical Industry 103
Table: Top 20 China / Hong Kong-Based Pharmaceutical Companies According To Market Capitalisation 103
Pharmaceutical Wholesale 104
Recent Developments 105
Traditional Chinese Medicine 111
Company Profile 114
Sinopharm 114
China Shijiazhuang Pharmaceutical Group 118
North China Pharmaceutical Corporation 121
Shanghai Pharmaceutical 124
GlaxoSmithKline 127
Pfizer 131
AstraZeneca 135
Merck KGaA 140
Sanofi 143
Novartis 147
Roche 152
Eli Lilly 157
Merck & Co 160
Bayer Schering Pharma 164
Demographic Forecast 168
Demographic Outlook 168
Table: China's Population By Age Group, 1990-2020 ('000)169
Table: China's Population By Age Group, 1990-2020 (% of total)170
Table: China's Key Population Ratios, 1990-2020 171
Table: China's Rural And Urban Population, 1990-2020 171
Glossary 172
Methodology 174
Pharmaceutical Expenditure Forecast Model 174
Healthcare Expenditure Forecast Model 174
Notes On Methodology 175
Risk/Reward Ratings Methodology 176
Ratings Overview 177
Table: Pharmaceutical Risk/Reward Ratings Indicators 177
Indicator Weightings 178


Read the full report:
China Pharmaceuticals and Healthcare Report Q1 2014
http://www.reportbuyer.com/pharma_healthcare/therapeutic/china_pharmaceuticals_healthcare_report_q1_2014.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer